Katie Insogna

Representative of her experience are the following matters:

• In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL 3094 (E.D Pa.): Serves as national counsel for Novo Nordisk in MDL and related state court litigation
• In re Zantac (Ranitidine) Products Liability Litigation, MDL 2924 (S.D. Fla.): Serves as co-national counsel for Sanofi in MDL and related state court litigations involving thousands of cancer claims and third party payor, medical monitoring, and consumer fraud class actions. Appointed by MDL Court to Leadership Development Committee.
• In re Eliquis Products Liability Litigation, MDL 2754 (S.D.N.Y.): National counsel for Bristol-Myers Squibb Co. and Pfizer in product liability litigation alleging that Eliquis causes bleeding, in which the DLA Piper team obtained landmark rulings finding that plaintiffs’ claims were preempted at the pleading stage (Utts v. Bristol-Myers Squibb Co., 226 F. Supp. 3d 166, 177 (S.D.N.Y. 2016) ("Utts I"); Utts v. Bristol-Myers Squibb Co., 251 F. Supp. 3d 644, 658 (S.D.N.Y. 2017) ("Utts II")). The MDL decisions were affirmed on appeal (Gibbons v. Bristol-Myers Squibb Co., No. 17-2638, 2d Cir. Mar. 26, 2019), a ruling the Drug & Device Law Blog called "the TwIqbal decision to end all TwIqbal decisions" in the preemption context and noted, "If anyone wonders why we consider preemption our side’s most powerful defense, Gibbons is Exhibit A."
• In re Proton Pump Inhibitor Products Liability Litigation (II), MDL 2789 (D.N.J): National counsel for Pfizer and Wyeth in product liability litigation alleging that proton pump inhibitors cause chronic kidney disease and other kidney injuries.
• Dunham v. Covidien, et al. and Krulewich v. Covidien, et al. (S.D.N.Y.): Argued successful motions to dismiss in product liability litigations alleging that Medtronic's hernia mesh was defective. Also serves as co-national counsel in MDL and related state court coordinated proceeding.
• Burnham v. Wyeth, et al. (D. Mass): Obtained successful ruling on motion to dismiss product liability claims related to Effexor.
• Essure Product Liability Litigation: Counsel for Bayer in product liability litigation alleging injuries caused by permanent contraceptive device.
• Counsel for medical device company in product liability matter involving cold therapy device.
• Advised pharmaceutical company on contractual provisions in supply agreements.

• Author, "A Numerical Analysis Of FDA Warning Letters In 2022," Law360, December 21, 2022
• Author, "Successfully Positioning Litigation for an MDL," American Bar Association, March 18, 2022
• Author, "FDA Q2 Warning Letters Show Agency Enforcement Priorities," Law360, July 19, 2021
• Author, "FDA Letters Suggest Scrutiny Of Virus And Vaping Products," Law360, April 8, 2021
• Author, "Massachusetts Supreme Court recognizes brand-name pharmaceutical makers owe duty to consumers of generic medications," DLA Piper, March 19, 2018
• Co-Author, "Plaintiff Fact Sheets In Mass Tort Discovery: Keys To Success," Law360, September 22, 2021